Physician investors, let’s talk stocks. When you hear “stocks,” what comes to mind? Flashing trading screens, technical charts, or maybe the adrenaline rush of day trading? Be honest with yourself: when you’re trading stocks, have you consistently pulled off 20% annual returns over the years? If you’re nodding yes, I’m calling your bluff. But if you’re serious about hitting that 20% average annual return to fast-track your early retirement or supercharge your nest egg, stick with me—this one’s for you.
I recently revisited a classic Charlie Rose interview with Warren Buffett, and let me tell you, his wisdom hit me like a ton of bricks. Buffett shared how, at just 11 years old, he was obsessed with trading stocks. He devoured every book on technical analysis—cover to cover, multiple times. Sounds familiar, right? But here’s the kicker: even with all that, he was still lost in the investment jungle. That is, until he stumbled across Ben Graham’s The Intelligent Investor. That book flipped his entire perspective.
Buffett stopped obsessing over charts and technicals. Instead, he started seeing stocks for what they really are: pieces of actual businesses. Once he made that mental shift, he didn’t care about daily price swings. In fact, after buying into a great company, he was perfectly fine ignoring the stock price for years. Think about that. When you view stocks as owning a slice of a wonderful business, doesn’t that feel less stressful? You bet it does.
Compare that to the day-trading grind. If you’re playing the short-term game, you’re glued to your screen, sweating every word from talking heads or, say, President Trump, because those headlines move markets. Ben Graham called this erratic force “Mr. Market”—a moody, unreliable character who quotes your stock up or down based on his feelings. But when you own a piece of a solid business, you don’t care if Mr. Market slashes the price on a whim. His quotes don’t change the value of the business itself.
This mindset is exactly what led me to double down on fundamentally strong biotech companies—like our “Mystery Telemedicine Stock”—back in early April. While Mr. Market was panicking, we saw the long-term value. That holding? It’s now up nearly 100%. Not bad, right? (FYI, I named this actual holding Mystery Telemedicine Stock due to fund compliance).
Here’s the takeaway: stop treating stocks like casino chips. Start seeing them as ownership in exceptional businesses. As physicians, you have a unique edge—you understand clinical medicine, drugs, and healthcare trends. Use that knowledge to identify great companies, buy in, and then let Father Time work his magic. Patience, paired with this mindset, can pave the way to an early—or downright luxurious—retirement.
So, next time you’re tempted to check those stock tickers every hour, remember: you’re not trading. You’re owning. And that’s how you build real wealth.
Stay smart, stay patient, and keep investing like a physician.
Dr. Harvey Tran, Evergrowth BioHealthcare Capital | Evergrowth Enterprises
Follow me on Social Media:
Enjoyed This? Stick Around! Subscribe to my newsletter for more insights on using your MD advantage in biotech investing.
Check out our Fund Presentation and our Skool Community Page.
Disclaimer: This blog is for educational and informational purposes only. It’s not a recommendation to buy, sell, or hold any stock. Always consult your investment advisor and do your due diligence before investing. In working smarter rather than harder, I wrote an initial draft based on my knowledge, experience, and insight. I then leverage AI to put the information together into this presentable format.
More Reads for You:
- Stop Trading Stocks, Start Owning Businesses
- The Case for Long-Term Biotech Investing: My Story with Jazz Pharmaceuticals
- Red Flags to Spot Pump-and-Dump Schemes: Protect Your Wealth, Docs
- Overcoming Fear in Biotech Investing: How to Thrive Amid Volatility
- Why You Should Pay Attention to Market Cap Size For Smarter Investing
- Investing for Physicians: How Much Do You Really Need for a Luxurious Retirement? (And How Biotech Could Get You There)
